BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30976382)

  • 1. Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science.
    Türková A; Zdrazil B
    Comput Struct Biotechnol J; 2019; 17():390-405. PubMed ID: 30976382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC Family Transporters.
    Liu X
    Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhou S; Shu Y
    Drug Metab Dispos; 2022 May; 50(9):1238-50. PubMed ID: 35644529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters.
    Chedik L; Bruyere A; Fardel O
    Xenobiotica; 2019 Mar; 49(3):363-374. PubMed ID: 29448871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition.
    Zhou F; Zhu L; Wang K; Murray M
    Adv Drug Deliv Rev; 2017 Jul; 116():21-36. PubMed ID: 27320645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transporter-Mediated Drug-Drug Interactions and Their Significance.
    Liu X
    Adv Exp Med Biol; 2019; 1141():241-291. PubMed ID: 31571167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy-Modulators of Cellular Entry or Pharmacokinetics?
    Brecht K; Schäfer AM; Meyer Zu Schwabedissen HE
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the active components of Punica granatum (pomegranate) with the essential renal and hepatic human Solute Carrier transporters.
    Li Z; Wang K; Zheng J; Cheung FS; Chan T; Zhu L; Zhou F
    Pharm Biol; 2014 Dec; 52(12):1510-7. PubMed ID: 25026340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling and ligand docking for solute carrier (SLC) transporters.
    Schlessinger A; Khuri N; Giacomini KM; Sali A
    Curr Top Med Chem; 2013; 13(7):843-56. PubMed ID: 23578028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal drug transporters and their significance in drug-drug interactions.
    Yin J; Wang J
    Acta Pharm Sin B; 2016 Sep; 6(5):363-373. PubMed ID: 27709005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition.
    Parvez MM; Sadighi A; Ahn Y; Keller SF; Enoru JO
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC Transporters: Structure, Function, and Drug Discovery.
    Colas C; Ung PM; Schlessinger A
    Medchemcomm; 2016 Jun; 7(6):1069-1081. PubMed ID: 27672436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters.
    Tátrai P; Schweigler P; Poller B; Domange N; de Wilde R; Hanna I; Gáborik Z; Huth F
    Drug Metab Dispos; 2019 Jul; 47(7):768-778. PubMed ID: 31068368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effects of the bioactive components isolated from Scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters.
    Xu F; Li Z; Zheng J; Gee Cheung FS; Chan T; Zhu L; Zhuge H; Zhou F
    J Pharm Sci; 2013 Nov; 102(11):4205-11. PubMed ID: 24018852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintillation proximity assay for measuring uptake by the human drug transporters hOCT1, hOAT3, and hOATP1B1.
    Lohmann C; Gelius B; Danielsson J; Skoging-Nyberg U; Hollnack E; Dudley A; Wahlberg J; Hoogstraate J; Gustavsson L
    Anal Biochem; 2007 Jul; 366(2):117-25. PubMed ID: 17555702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of human solute carrier transporters by multikinase inhibitors.
    Johnston RA; Rawling T; Chan T; Zhou F; Murray M
    Drug Metab Dispos; 2014 Nov; 42(11):1851-7. PubMed ID: 25165131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
    Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Substrate Characterization of 22 Antituberculosis Drugs for Multiple Solute Carrier (SLC) Uptake Transporters
    Parvez MM; Kaisar N; Shin HJ; Lee YJ; Shin JG
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 30012768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
    Dolberg AM; Reichl S
    Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.